-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Phathom Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2024.
- Phathom Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$14.8M, a 94.9% decline year-over-year.
- Phathom Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$51.5M, a 56.2% decline year-over-year.
- Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$34.3M, a 35.6% decline from 2022.
- Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$25.3M, a 187% decline from 2021.
- Phathom Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$8.8M, a 159% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)